HuGE Literature Finder
Records
1
-
23
| MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer. Pathology oncology research : POR 2022 12 28 1610697. Ko Jihoon, Jung Jaeyun, Kim Seung Tae, Hong Jung Yong, Park Sehhoon, Park Joon Oh, Park Young Suk, Lim Ho Yeong, Ahn Soomin, Kim Kyoung-Mee, Kang Won Ki, Lee Jeey |
| Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib. Translational lung cancer research 2021 4 10 (3): 1525-1535. Li Jingjing, Zhang Bin, Zhang Yu, Xu Feng, Zhang Zhenfa, Shao Lin, Yan Chunhe, Ulivi Paola, Denis Marc G, Christopoulos Petros, Thomas de Montpréville Vincent, Bernicker Eric H, van der Wekken Anthonie J, Wang Changli, Yue Dongshe |
| Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease. Scientific reports 2021 1 11 (1): 667. Vargas Ana Cristina, Gray Lesley-Ann, White Christine L, Maclean Fiona M, Grimison Peter, Ardakani Nima Mesbah, Bonar Fiona, Algar Elizabeth M, Cheah Alison L, Russell Peter, Mahar Annabelle, Gill Anthony |
| Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data. Oncoimmunology 2021 2 10 (1): 1865653. Dudnik Elizabeth, Moskovitz Mor, Rottenberg Yakir, Lobachov Anastasiya, Mandelboim Rinat, Shochat Tzippy, Urban Damien, Wollner Mira, Nechushtan Hovav, Rotem Ofer, Zer Alona, Daher Sameh, Bar Jair, |
| Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients. Frontiers in oncology 2021 4 11 647598. Yang Jie, Li Hefei, Li Ben, Li Wei, Guo Qiang, Hu Ling, Song Zizheng, Zhou B |
| Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer. International journal of radiation oncology, biology, physics 2020 2 107 (2): 353-359. Schlosser Shir, Rabinovitch Rachel, Shatz Zina, Galper Shira, Shahadi-Dromi Ilanit, Finkel Sara, Jacobson Galia, Rasco Adi, Friedman Eitan, Laitman Yael, Evron Ella, Bernstein Rinat, Weiss Ilana, Sklair-Levy Miri, Ben-David Merav |
| Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas. International journal of clinical oncology 2019 May . Liang Xiaohong, Li Qing, Xu Bin, Hu Song, Wang Qianyun, Li Yan, Zong Yun, Zhang Sujuan, Li Cho |
| Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma. JCI insight 2019 5 4 (13): . Lee Chang-Lung, Mowery Yvonne M, Daniel Andrea R, Zhang Dadong, Sibley Alexander B, Delaney Joe R, Wisdom Amy J, Qin Xiaodi, Wang Xi, Caraballo Isibel, Gresham Jeremy, Luo Lixia, Van Mater David, Owzar Kouros, Kirsch David |
| Population-level effect of molecular testing and targeted therapy in patients with advanced pulmonary adenocarcinoma: a prospective cohort study. Virchows Archiv : an international journal of pathology 2018 Apr 472 (4): 581-588. Schwegler Christine, Kaufmann Dinu, Pfeiffer David, Aebi Stefan, Diebold Joachim, Gautschi Oliv |
| MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy. Clinical lung cancer 2018 07 19 (4): e441-e463. Reis Henning, Metzenmacher Martin, Goetz Moritz, Savvidou Nikoleta, Darwiche Kaid, Aigner Clemens, Herold Thomas, Eberhardt Wilfried E, Skiba Charlotte, Hense Jörg, Virchow Isabel, Westerwick Daniela, Bogner Simon, Ting Saskia, Kasper Stefan, Stuschke Martin, Nensa Felix, Herrmann Ken, Hager Thomas, Schmid Kurt W, Schuler Martin, Wiesweg Marc |
| The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials. European journal of cancer (Oxford, England : 1990) 2018 4 95 20-29. McVeigh Terri Patricia, Sundar Raghav, Diamantis Nikolaos, Kaye Stan B, Banerji Udai, Lopez Juanita S, de Bono Johann, van der Graaf Winette T A, George Angela |
| Identification of genome variations in patients with lung adenocarcinoma using whole genome re?sequencing. Molecular medicine reports 2017 10 16 (6): 9464-9472. Li Guiyuan, Mei Yunqing, Yang Fan, Yi Shengming, Wang Lem |
| Incidence of Lung Adenocarcinoma Biomarker in a Caribbean and African Caribbean Population. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Feb . Leduc Nicolas, Ahomadegbe Christelle, Agossou Moustapha, Aline-Fardin Aude, Mahjoubi Linda, Dufrenot-PetitJean-Roget Leïla, Grossat Nathalie, Vinh-Hung Vincent, Lamy Aude, Sabourin Jean-Christophe, Molinie Vince |
| Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. Cancer discovery 2015 Aug 5 (8): 850-9. Frampton Garrett M, Ali Siraj M, Rosenzweig Mark, Chmielecki Juliann, Lu Xinyuan, Bauer Todd M, Akimov Mikhail, Bufill Jose A, Lee Carrie, Jentz David, Hoover Rick, Ou Sai-Hong Ignatius, Salgia Ravi, Brennan Tim, Chalmers Zachary R, Jaeger Savina, Huang Alan, Elvin Julia A, Erlich Rachel, Fichtenholtz Alex, Gowen Kyle A, Greenbowe Joel, Johnson Adrienne, Khaira Depinder, McMahon Caitlin, Sanford Eric M, Roels Steven, White Jared, Greshock Joel, Schlegel Robert, Lipson Doron, Yelensky Roman, Morosini Deborah, Ross Jeffrey S, Collisson Eric, Peters Malte, Stephens Philip J, Miller Vincent |
| Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Cancer 2015 Feb 121 (3): 448-56. Villaruz Liza C, Socinski Mark A, Abberbock Shira, Berry Lynne D, Johnson Bruce E, Kwiatkowski David J, Iafrate A John, Varella-Garcia Marileila, Franklin Wilbur A, Camidge D Ross, Sequist Lecia V, Haura Eric B, Ladanyi Mark, Kurland Brenda F, Kugler Kelly, Minna John D, Bunn Paul A, Kris Mark |
| Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Jan 26 (1): 13-21. Sorich M J, Wiese M D, Rowland A, Kichenadasse G, McKinnon R A, Karapetis C |
| Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations. International journal of environmental research and public health 2014 Sep 11 (9): 9491-502. Yilmaz Ahmet, Mohamed Nehad, Patterson Kara A, Tang Yan, Shilo Konstantin, Villalona-Calero Miguel A, Davis Michael E, Zhou Xiaoping, Frankel Wendy, Otterson Gregory A, Beall Howard D, Zhao Weiqia |
| Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations. Clinical chemistry 2014 Jul 60 (7): 1004-11. Liu Xiaoying, Mody Kabir, de Abreu Francine B, Pipas J Marc, Peterson Jason D, Gallagher Torrey L, Suriawinata Arief A, Ripple Gregory H, Hourdequin Kathryn C, Smith Kerrington D, Barth Richard J, Colacchio Thomas A, Tsapakos Michael J, Zaki Bassem I, Gardner Timothy B, Gordon Stuart R, Amos Christopher I, Wells Wendy A, Tsongalis Gregory |
| Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status. PloS one 2014 9 (8): e103551. Lee Jeeyun, Jain Anjali, Kim Phillip, Lee Tani, Kuller Anne, Princen Fred, In-GuDo , Kim Suk Hyeong, Park Joon Oh, Park Young Suk, Singh Sharat, Kim Hee Che |
| Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients. OncoTargets and therapy 2014 7 513-24. Li Hang, Hu Haichuan, Wang Rui, Pan Yunjian, Wang Lei, Li Yuan, Zhang Yang, Ye Ting, Zhang Yiliang, Li Bin, Shen Lei, Sun Yihua, Chen Haiqu |
| Comparison of KRAS genotype: therascreen assay vs. LNA-mediated qPCR clamping assay. Clinical colorectal cancer 2013 Sep 12 (3): 195-203.e2. Chang Shao-Chun, Denne Jonathan, Zhao Luping, Horak Christine, Green George, Khambata-Ford Shirin, Bray Christopher, Celik Ilhan, Van Cutsem Eric, Harbison Christoph |
| High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort. PloS one 2013 8 (7): e69026. Mitchell Gillian, Ballinger Mandy L, Wong Stephen, Hewitt Chelsee, James Paul, Young Mary-Anne, Cipponi Arcadi, Pang Tiffany, Goode David L, Dobrovic Alex, Thomas David M, |
| Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Mar 27 (8): 1250-6. Gonzalez Kelly D, Noltner Katie A, Buzin Carolyn H, Gu Dongqing, Wen-Fong Cindy Y, Nguyen Vu Q, Han Jennifer H, Lowstuter Katrina, Longmate Jeffrey, Sommer Steve S, Weitzel Jeffrey |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: